Philip Morris International: all 55 studies

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• Nicotine Pharmacokinetics of THS Single Use of a Regular or a Menthol Stick Compared to CIGCompletedNCT05789420Not applicableResults posted
• Reduced Exposure to HPHC in Smokers Switching From Cigarettes to Different Versions of THSCompletedNCT05599451Not applicableResults posted
• Reduced HPHC Exposure in Cigarette Smokers Switching to P4M3 Gen. 2.0 Compared to Continuing Smoking, or Smoking AbstinenceCompletedNCT05487456Not applicableResults posted
• Reduction of Exposure, Inflammation, and Oxidative Stress Following at Least 2 Years of Switching to THS Use Compared to Cigarette SmokingCompletedNCT05385055Results posted
• Nicotine Pharmacokinetics Following Use of the P4M3 Gen 2.0 E-Cigarette Compared to Smoking CigarettesCompletedNCT05383508Not applicableResults posted
• Nicotine Pharmacokinetics and Subjective Effects of Nicotine Pouch 1.0 Compared to Velo® Ice Cool and Zyn® Cool Mint Mini Dry in Healthy SmokersCompletedNCT05317195Not applicableResults posted
• Product Use and Adaptation, Safety and Tolerability of P3P in Adult Healthy Smokers Switching to itCompletedNCT03953183Not applicableResults posted
• Effect of Switching From Cigarette Smoking to IQOS on Exercise CapacityCompletedNCT03887117Not applicableResults posted
• Comparison of Abdominal Aortic Aneurysm Growth in Adult Smoking Patients Who Either Switch to IQOS, Continue Smoking, or Quit Smoking.CompletedNCT03837704Not applicableResults posted
• Real-Life Passive Exposure Assessment of IQOSCompletedNCT03550989Results posted
• Study to Investigate the Nicotine Pharmacokinetic Profiles and Pharmacodynamic Effects of P4M3 VariantsCompletedNCT03379740Not applicableResults posted
• Nicotine Pharmacokinetics and Pharmacodynamics, Safety and Tolerability of P3PCompletedNCT03369340Not applicableResults posted
• Effect of Switching From Cigarette Smoking to the Use of IQOS on Periodontitis Treatment OutcomeCompletedNCT03364751Not applicableResults posted
• Prefatory Study to Explore Changes in Nasal Mucociliary Clearance and to Standardize Nasal Scraping ProcedureCompletedNCT03086707Not applicableResults posted
• Japanese Post-Market Cohort StudyTerminatedNCT03020667Results posted
• A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2CompletedNCT02649556Not applicableResults posted
• User Acceptability of a Nicotine Lactate Delivery System (P3L)CompletedNCT02643693Not applicableResults posted
• Reduced Exposure Study Using the CHTP 1.2 With 5 Days in a Confinement Setting Followed by 85 Days in an Ambulatory Setting.CompletedNCT02641587Not applicableResults posted
• Nicotine Pharmacokinetic and Pharmacodynamics Profile, Safety and Tolerability of P3LCompletedNCT02532374Not applicableResults posted
• Reduced Exposure Study Using CHTP 1.0 During 5 Days in Confinement.CompletedNCT02503254Not applicableResults posted
• Nicotine Pharmacokinetic Profile of the CHTP 1.1 MCompletedNCT02466412Not applicableResults posted
• A Smoking Cessation Study to Understand the Biological and Functional Changes After One Year of Smoking CessationCompletedNCT02432729Results posted
• Evaluation of Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2 for 26 WeeksCompletedNCT02396381Not applicableResults posted
• Reduced Exposure Study Using THS 2.2 Menthol With 5 Days in a Confinement Setting Followed by 86 Days in an Ambulatory SettingCompletedNCT01989156Not applicableResults posted
• Reduced Exposure Study Using THS 2.2 Menthol With 5 Days in a Confinement Setting and 85 Days in an Ambulatory SettingCompletedNCT01970995Not applicableResults posted
• Reduced Exposure Study in Smokers Using the Tobacco Heating System 2.2 (THS 2.2) for 5 Days in a Confinement SettingCompletedNCT01970982Not applicableResults posted
• Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 (THS 2.2)CompletedNCT01967732Not applicableResults posted
• Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 Menthol (THS 2.2 Menthol)CompletedNCT01967719Not applicableResults posted
• Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 Menthol (THS 2.2 Menthol).CompletedNCT01967706Not applicableResults posted
• Reduced Exposure Study in Smokers Using THS 2.2 With 5 Days in a Confinement Setting.CompletedNCT01959932Not applicableResults posted
• Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 (THS 2.2)CompletedNCT01959607Not applicableResults posted
• Chronic Obstructive Pulmonary Disease (COPD) Biomarker Identification StudyCompletedNCT01780298Results posted
• Controlled Study of the Ability of a Smokefree Tobacco Product to Increase the Quit Rate Among Cigarette SmokersCompletedNCT00843622Phase 4Results posted
• Pharmacokinetics and Pharmacodynamics of THS With LEVIA Compared to THS With TEREA and to CigarettesCompletedNCT07459712Not applicable
• Assessment of HPHC Exposure in Smokers Switching to THS/TP18 With Different Device VariantsActive, not recruitingNCT07443631Not applicable
• Exploratory Randomized, Controlled, Dose-response Study on the Impact of Nicotine From Five Variants of a Nicotine Tablet (NICOTINE TABLET) on AttentionCompletedNCT07408180Not applicable
• Nicotine Pharmacokinetics and Pharmacodynamics of Two Variants of VM 1.0 Compared to Cigarettes in Adult Current SmokersActive, not recruitingNCT07135648Not applicable
• Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THSActive, not recruitingNCT07108166Not applicable
• Randomized Controlled Trial to Evaluate the Impact of ZYN Nicotine Pouch Products on Cigarette Usage and BoExp in Adult Smokers Over a 12-week PeriodCompletedNCT06568900Not applicable
• Pharmacokinetics and Comparative Bioavailability of Nicotine From Two Variants of NP2, NP2-4mg and NP2-6mg, Compared to Nicotine Lozenge 4mg (Loz-4mg) and Nicotine Gum 4mg (Gum-4mg)CompletedNCT06171490Not applicable
• Effect of Switching From Cigarette Smoking to THS on Disease Progression in Mild to Moderate COPD Subjects With Chronic Bronchitis Symptoms.TerminatedNCT05569005Not applicable
• Effect of Switching From Cigarette Smoking to THS on Systemic Endothelial Function in Subjects With Established Atherosclerotic DiseaseWithdrawnNCT05566678Not applicable
• Cross-Sectional Survey on the Use of Tobacco Products - London (UK)TerminatedNCT03527030
• Cross-Sectional Survey on the Use of Tobacco Products - GermanyTerminatedNCT03527017
• Cross-Sectional Survey on the Use of Tobacco Products - ItalyTerminatedNCT03527004
• Single-Dose Bioequivalence Study Comparing Two 4 mg Nicotine LozengesCompletedNCT03432312Phase 1
• Single-Dose Bioequivalence Study Comparing Two 2 mg Nicotine LozengesCompletedNCT03432273Phase 1
• Comparison of Pharmacokinetic Profiles of 3 New Nicotine Gum Formulations With a Reference GumCompletedNCT02356913Phase 1
• Determination of Biomarkers of Exposure and Biomarkers of Potential Harm in Asian Adult Cigarette SmokersCompletedNCT02103751
• Exploratory THS 2.1 Biomarkers of Exposure StudyCompletedNCT01780714Not applicable
• Exploratory THS 2.1 Nicotine Pharmacokinetics and Safety StudyCompletedNCT01780688Not applicable
• Smoking Research StudyCompletedNCT01465880Not applicable
• European Exposure StudyCompletedNCT01237912
• Investigate the Exposure to Selected Smoke Constituents in Smokers Switching to Distillation Based Smoking ArticleCompletedNCT00812279Not applicable
• Serbian Smoking Reduction/Cessation Trial (2SRT)CompletedNCT00601042Phase 4

← Philip Morris International overview and focus areas